Have a personal or library account? Click to login
The Prognostic Role of Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio in the Risk of Major Adverse Cardiovascular Events and Mortality in Patients with COVID-19: a State-of-the-Art Review Cover

The Prognostic Role of Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio in the Risk of Major Adverse Cardiovascular Events and Mortality in Patients with COVID-19: a State-of-the-Art Review

Open Access
|Jun 2024

References

  1. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Available from: https://covid19.who.int/ [Accessed 15 November 2023]
  2. Stoian A, Bajko Z, Stoian M, et al. The Occurrence of Acute Disseminated Encephalomyelitis in SARS-CoV-2 Infection/Vaccination: Our Experience and a Systematic Review of the Literature. Vaccines. 2023;11(7):1225. doi: 10.3390/vaccines11071225
  3. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3
  4. Mureșan AV, Russu E, Arbănași EM, et al. Negative Impact of the COVID-19 Pandemic on Kidney Disease Management—A Single-Center Experience in Romania. J Clin Med. 2022;11(9):2452. doi: 10.3390/jcm11092452
  5. Arbanasi EM, Kaller R, Muresan VA, Voidazan S, Arbanasi EMA, Russu E. Impact of COVID-19 pandemic on Vascular Surgery Unit activity in Central Romania. Front Surg. 2022;9:883935. doi: 10.3389/fsurg.2022.883935
  6. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
  7. Elezkurtaj S, Greuel S, Ihlow J, et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci Rep. 2021;11(1):4263. doi: 10.1038/s41598-021-82862-5
  8. Hogea T, Suciu BA, Chinezu L, et al. Pregnancy-Associated Spontaneous Coronary Acute Dissection as a Cause of Sudden Cardiac Death—Autopsy Findings and Literature Review: Is COVID-19 Related? Medicina. 2023;59(7):1257. doi: 10.3390/medicina59071257
  9. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504. doi: 10.1016/j.intimp.2020.106504
  10. Seyit M, Avci E, Nar R, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021;40:110–114. doi: 10.1016/j.ajem.2020.11.058
  11. Erdal E, İnanir M. Platelet-to-lymphocyte ratio (PLR) and Plateletcrit (PCT) in young patients with morbid obesity. Rev Assoc Med Bras. 2019;65:1182–1187. doi: 10.1590/1806-9282.65.9.1182
  12. Dujardin RWG, Hilderink BN, Haksteen WE, et al. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients. Thrombosis Research. 2020;196:308–312. doi: 10.1016/j.thromres.2020.09.017
  13. Russu E, Mureșan AV, Arbănași EM, et al. The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease. J Clin Med. 2022;11(9):2620. doi: 10.3390/jcm11092620
  14. Melinte RM, Arbănași EM, Blesneac A, et al. Inflammatory Biomarkers as Prognostic Factors of Acute Deep Vein Thrombosis Following the Total Knee Arthroplasty. Medicina. 2022;58(10):1502. doi: 10.3390/medicina58101502
  15. Niculescu R, Russu E, Arbănași EM, et al. Carotid Plaque Features and Inflammatory Biomarkers as Predictors of Restenosis and Mortality Following Carotid Endarterectomy. Int J Environ Res Public Health. 2022;19(21):13934. doi: 10.3390/ijerph192113934
  16. Kaller R, Arbănași EM, Mureșan AV, et al. The Predictive Value of Systemic Inflammatory Markers, the Prognostic Nutritional Index, and Measured Vessels’ Diameters in Arteriovenous Fistula Maturation Failure. Life. 2022;12(9):1447. doi: 10.3390/life12091447
  17. Arbănași EM, Mureșan AV, Arbănași EM, et al. The Neutrophilto-Lymphocyte Ratio’s Predictive Utility in Acute Pulmonary Embolism: Systematic Review. Journal Of Cardiovascular Emergencies. 2022;8(2):25–30. doi: 10.2478/jce-2022-0005
  18. Vunvulea V, Budișcă OA, Arbănași EM, et al. The Predictive Role of Systemic Inflammatory Markers in the Development of Acute Kidney Failure and Mortality in Patients with Abdominal Trauma. Journal of Personalized Medicine. 2022;12(12):2045. doi: 10.3390/jpm12122045
  19. Kaller R, Russu E, Arbănași EM, et al. Intimal CD31-Positive Relative Surfaces Are Associated with Systemic Inflammatory Markers and Maturation of Arteriovenous Fistula in Dialysis Patients. J Clin Med. 2023;12(13):4419. doi: 10.3390/jcm12134419
  20. Abrishami A, Eslami V, Baharvand Z, et al. Epicardial adipose tissue, inflammatory biomarkers and COVID-19: Is there a possible relationship? Int Immunopharmacol. 2021;90:107174. doi: 10.1016/j.intimp.2020.107174
  21. Pakos IS, Lo KB, Salacup G, et al. Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19. Eur J Haematol. 2020;105(6):773–778. doi: 10.1111/ejh.13509
  22. Allahverdiyev S, Quisi A, Harbalıoğlu H, et al. The Neutrophil to Lymphocyte Ratio and In-Hospital All-Cause Mortality in Patients with COVID-19. Eur J Ther. 2020;26(3):251–256. doi: 10.5152/eurjther.2020.20067
  23. Zeng ZY, Feng SD, Chen GP, Wu JN. Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study. BMC Infect Dis. 2021;21(1):80. doi: 10.1186/s12879-021-05796-3
  24. Rose J, Suter F, Furrer E, Sendoel A, Stüssi-Helbling M, Huber LC. Neutrophile-to-Lymphocyte Ratio (NLR) Identifies Patients with Coronavirus Infectious Disease 2019 (COVID-19) at High Risk for Deterioration and Mortality—A Retrospective, Monocentric Cohort Study. Diagnostics. 2022;12(5):1109. doi: 10.3390/diagnostics12051109
  25. Halmaciu I, Arbănași EM, Kaller R, et al. Chest CT Severity Score and Systemic Inflammatory Biomarkers as Predictors of the Need for Invasive Mechanical Ventilation and of COVID-19 Patients’ Mortality. Diagnostics. 2022;12(9):2089. doi: 10.3390/diagnostics12092089
  26. Arbănași EM, Halmaciu I, Kaller R, et al. Systemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(10):2379. doi: 10.3390/diagnostics12102379
  27. Mureșan AV, Hălmaciu I, Arbănași EM, et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(11):2757. doi: 10.3390/diagnostics12112757
  28. Citu C, Gorun F, Motoc A, et al. The Predictive Role of NLR, d-NLR, MLR, and SIRI in COVID-19 Mortality. Diagnostics. 2022;12(1):122. doi: 10.3390/diagnostics12010122
  29. Ghobadi H, Mohammadshahi J, Javaheri N, Fouladi N, Mirzazadeh Y, Aslani MR. Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients. Front Med (Lausanne). 2022;9:916453. doi: 10.3389/fmed.2022.916453
  30. Regolo M, Vaccaro M, Sorce A, et al. Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients. J Clin Med. 2022;11(8):2235. doi: 10.3390/jcm11082235
  31. Seyfi S, Azadmehr A, Ezoji K, et al. Mortality in ICU COVID-19 Patients Is Associated with Neutrophil-to-Lymphocyte Ratio (NLR): Utility of NLR as a Promising Immunohematological Marker. Interdiscip Perspect Infect Dis. 2023;2023:e9048749. doi: 10.1155/2023/9048749
  32. Zhan L, Liu Y, Cheng Y, Guo W, Yang J. Predictive Value of Neutrophil/Lymphocyte Ratio (NLR) on Cardiovascular Events in Patients with COVID-19. Int J Gen Med. 2021;14:3899–3907. doi: 10.2147/IJGM.S317380
  33. Predenciuc A, Casian D, Culiuc V. Outcomes of Surgical Revascularization for Acute Limb Ischemia in COVID-19 Patients Comparing to Noninfected Cohort: A Single-Center Observational Prospective Study. Ann Vasc Surg. 2023;91:81–89. doi: 10.1016/j.avsg.2022.11.024
  34. Fois AG, Paliogiannis P, Scano V, et al. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules. 2020;25(23):5725. doi: 10.3390/molecules25235725
  35. Strazzulla A, Abroug Ben Halima S, Chouchane I, et al. The Predictive Value of Cell Blood Count Parameters to Diagnose Pulmonary Embolism in Patients with SARS-CoV-2 Infection: A Case Control Study. Antibiotics. 2022;11(1):60. doi: 10.3390/antibiotics11010060
  36. Moradian N, Gouravani M, Salehi MA, et al. Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality. Eur Cytokine Netw. 2020;31(3):81–93. doi: 10.1684/ecn.2020.0451
  37. Yildiz H, Castanares-Zapatero D, Pierman G, et al. Validation of Neutrophil-to-Lymphocyte Ratio Cut-off Value Associated with High In-Hospital Mortality in COVID-19 Patients. Int J Gen Med. 2021;14:5111–5117. doi: 10.2147/IJGM.S326666
  38. Karaaslan T, Karaaslan E. Predictive Value of Systemic Immune-inflammation Index in Determining Mortality in COVID-19 Patients. The Journal of Critical Care Medicine. 2022;8(3):156–164. doi: 10.2478/jccm-2022-0013
  39. Kudlinski B, Zgoła D, Stolińska M, et al. Systemic Inflammatory Predictors of In-Hospital Mortality in COVID-19 Patients: A Retrospective Study. Diagnostics. 2022;12(4):859. doi: 10.3390/diagnostics12040859
  40. Khorvash F, Najafi MA, Kheradmand M, Saadatnia M, Chegini R, Najafi F. New-onset acute ischemic stroke following COVID-19: A case–control study. J Res Med Sci. 2022;27:31. doi: 10.4103/jrms.jrms_255_21
DOI: https://doi.org/10.2478/jce-2024-0010 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 61 - 70
Submitted on: Dec 17, 2023
Accepted on: Jan 9, 2024
Published on: Jun 27, 2024
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Eliza Mihaela Arbănași, Eliza Russu, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.